Home|Best-Bschool-in-india-2018

DSIJ Mindshare

Market Wrap: Benchmark indices close on a higher note while Nifty Pharma outperforms! Market Wrap: Benchmark indices close on a higher note while Nifty Pharma outperforms!

Market Wrap: Benchmark indices close on a higher note while Nifty Pharma outperforms!

On Monday, Benchmark indices concluded the trading day on a positive note as Sensex closed moderately higher by 0.39 per cent concluding at 72,708.16 level, while Nifty also surged by 0.37 per cent and closed at 22,122.25 level.

Siddharth Mane 0 3044 Article rating: 3.9

On February 16, 2024, foreign institutional investors (FII) bought shares worth Rs 253.28 crore, while domestic institutional investors (DII) purchased shares worth Rs 1,571 crore.

Read more
Multibagger mutual fund: This thematic fund has delivered 100 per cent return in just one year! Multibagger mutual fund: This thematic fund has delivered 100 per cent return in just one year!

Multibagger mutual fund: This thematic fund has delivered 100 per cent return in just one year!

A lumpsum investment of Rs 1,00,000 in this fund would have turned to Rs 2,05,570 in just a year.

Karan Dsij 0 3069 Article rating: 4.2

Investment in this scheme is accessible to all, with a minimum SIP amount set at Rs 500, making it inclusive and appealing to a broad spectrum of investors. Delving deeper into its asset allocation, as of January 31, 2024, the fund has strategically allocated 93.43 per cent of its assets in equity, with the remaining 6.57 per cent parked in cash and cash equivalents.

Read more
5:1 stock split & 25,000 per cent returns: Multibagger micro-cap stock hit 20 per cent upper circuit on February 19 – scrip trades at high ROE and high ROCE 5:1 stock split & 25,000 per cent returns: Multibagger micro-cap stock hit 20 per cent upper circuit on February 19 – scrip trades at high ROE and high ROCE

5:1 stock split & 25,000 per cent returns: Multibagger micro-cap stock hit 20 per cent upper circuit on February 19 – scrip trades at high ROE and high ROCE

The stock has delivered mind-boggling returns for investors, generating multibagger returns of 1,800 per cent in just 1 year.

Kiran Shroff 0 10891 Article rating: 3.7

The shares of the company have an ROE of 71 per cent and a ROCE of 103 per cent.

Read more
RSS
First613614615616618620621622Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList